181 related articles for article (PubMed ID: 9499606)
1. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
[TBL] [Abstract][Full Text] [Related]
2. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.
Burrows NP; Nicholls AC; Yates JR; Gatward G; Sarathachandra P; Richards A; Pope FM
J Invest Dermatol; 1996 Jun; 106(6):1273-6. PubMed ID: 8752669
[TBL] [Abstract][Full Text] [Related]
3. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
[TBL] [Abstract][Full Text] [Related]
5. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
[TBL] [Abstract][Full Text] [Related]
6. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II).
Loughlin J; Irven C; Hardwick LJ; Butcher S; Walsh S; Wordsworth P; Sykes B
Hum Mol Genet; 1995 Sep; 4(9):1649-51. PubMed ID: 8541855
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics in classic Ehlers-Danlos syndrome.
Malfait F; De Paepe A
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
[TBL] [Abstract][Full Text] [Related]
9. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
[TBL] [Abstract][Full Text] [Related]
10. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
[TBL] [Abstract][Full Text] [Related]
11. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome.
Wenstrup RJ; Florer JB; Cole WG; Willing MC; Birk DE
J Cell Biochem; 2004 May; 92(1):113-24. PubMed ID: 15095409
[TBL] [Abstract][Full Text] [Related]
12. Type IV Ehlers-Danlos syndrome with aspirin sensitivity. A family study.
Grenko RT; Burns SL; Golden EA; Byers PH; Bovill EG
Arch Pathol Lab Med; 1993 Oct; 117(10):989-92. PubMed ID: 8215841
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC
Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
[TBL] [Abstract][Full Text] [Related]
14. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
15. Correlation of linkage data with phenotype in eight families with Stickler syndrome.
Wilkin DJ; Mortier GR; Johnson CL; Jones MC; de Paepe A; Shohat M; Wildin RS; Falk RE; Cohn DH
Am J Med Genet; 1998 Nov; 80(2):121-7. PubMed ID: 9805127
[TBL] [Abstract][Full Text] [Related]
16. COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II.
Greenspan DS; Northrup H; Au KS; McAllister KA; Francomano CA; Wenstrup RJ; Marchuk DA; Kwiatkowski DJ
Genomics; 1995 Feb; 25(3):737-9. PubMed ID: 7759113
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
De Paepe A; Nuytinck L; Hausser I; Anton-Lamprecht I; Naeyaert JM
Am J Hum Genet; 1997 Mar; 60(3):547-54. PubMed ID: 9042913
[TBL] [Abstract][Full Text] [Related]
18. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I).
Wenstrup RJ; Langland GT; Willing MC; D'Souza VN; Cole WG
Hum Mol Genet; 1996 Nov; 5(11):1733-6. PubMed ID: 8923000
[TBL] [Abstract][Full Text] [Related]
19. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
20. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).
Schwarze U; Atkinson M; Hoffman GG; Greenspan DS; Byers PH
Am J Hum Genet; 2000 Jun; 66(6):1757-65. PubMed ID: 10796876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
